» Articles » PMID: 29878104

Burden of Severe Norovirus Disease in Taiwan, 2003-2013

Overview
Journal Clin Infect Dis
Date 2018 Jun 8
PMID 29878104
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the increasingly recognized role of norovirus in global acute gastroenteritis (AGE), specific estimates of the associated disease burden remain sparse, primarily due to limited availability of sensitive norovirus diagnostics in the clinical setting. We sought to estimate the incidence of norovirus-associated hospitalizations by age group in Taiwan using a previously developed indirect regression method.

Methods: AGE-related hospitalizations in Taiwan were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes abstracted from a national database; population data were provided from the Department of Household Registration Affairs. Population and hospitalizations were aggregated by month and year (July 2003-June 2013) and grouped by age: <5 years, 5-19 years, 20-64 years, and ≥65 years. Monthly counts of cause-unspecified AGE hospitalizations were modeled as a function of counts of known causes, and the residuals were then analyzed to estimate norovirus-associated hospitalizations.

Results: Over the study period, an annual mean of 101400 gastroenteritis-associated hospitalizations occurred in Taiwan (44 per 10000 person-years), most of which (83%) had no specified cause. The overall estimated rate of norovirus-associated hospitalizations was 6.7 per 10000 person-years, with the highest rates in children aged <5 years (63.7/10000 person-years). Predicted norovirus peaked in 2006-2007 and 2012-2013.

Conclusions: Our study is one of the first to generate a population-based estimate of severe norovirus disease incidence in Asia, and highlights the large burden of norovirus in Taiwan, particularly in children. Predicted peak norovirus seasons coincided with the emergence of new strains and resulting pandemics, supporting the validity of the estimates.

Citing Articles

Norovirus Genogroup II Epidemics and the Potential Effect of Climate Change on Norovirus Transmission in Taiwan.

Chiu S, Hu S, Liao L, Chen Y, Lin J Viruses. 2022; 14(3).

PMID: 35337048 PMC: 8948982. DOI: 10.3390/v14030641.


Prevalence, Distribution, and Genotypes of Adenovirus and Norovirus in the Puzi River and Its Tributaries and the Surrounding Areas in Taiwan.

Nagarajan V, Chen J, Hsu B, Hsu G, Wang J, Hussain B Geohealth. 2022; 5(12):e2021GH000465.

PMID: 34977444 PMC: 8686652. DOI: 10.1029/2021GH000465.


Epidemiology and evolution of Norovirus in China.

Wei N, Ge J, Tan C, Song Y, Wang S, Bao M Hum Vaccin Immunother. 2021; 17(11):4553-4566.

PMID: 34495811 PMC: 8828116. DOI: 10.1080/21645515.2021.1961465.


Estimation of Risk of Death Attributable to Acute Gastroenteritis Not Caused by Infection Among Hospitalized Adults in England.

Alexandridou M, Cattaert T, Verstraeten T Clin Epidemiol. 2021; 13:309-315.

PMID: 33935520 PMC: 8079255. DOI: 10.2147/CLEP.S296516.


Burden of Norovirus in the United States, as Estimated Based on Administrative Data: Updates for Medically Attended Illness and Mortality, 2001-2015.

Burke R, Mattison C, Pindyck T, Dahl R, Rudd J, Bi D Clin Infect Dis. 2020; 73(1):e1-e8.

PMID: 32291450 PMC: 8112883. DOI: 10.1093/cid/ciaa438.


References
1.
Payne D, Vinje J, Szilagyi P, Edwards K, Staat M, Weinberg G . Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med. 2013; 368(12):1121-30. PMC: 4618551. DOI: 10.1056/NEJMsa1206589. View

2.
Chan M, Leung T, Chung T, Kwok A, Nelson E, Lee N . Virus Genotype Distribution and Virus Burden in Children and Adults Hospitalized for Norovirus Gastroenteritis, 2012-2014, Hong Kong. Sci Rep. 2015; 5:11507. PMC: 4469980. DOI: 10.1038/srep11507. View

3.
Grytdal S, Rimland D, Shirley S, Rodriguez-Barradas M, Goetz M, Brown S . Incidence of Medically-Attended Norovirus-Associated Acute Gastroenteritis in Four Veteran's Affairs Medical Center Populations in the United States, 2011-2012. PLoS One. 2015; 10(5):e0126733. PMC: 4440768. DOI: 10.1371/journal.pone.0126733. View

4.
Lopman B, Steele D, Kirkwood C, Parashar U . The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. PLoS Med. 2016; 13(4):e1001999. PMC: 4846155. DOI: 10.1371/journal.pmed.1001999. View

5.
Liu L, Kuo T, Wu C, Liao W, Hall A, Wu F . Recombinant GII.P16-GII.2 Norovirus, Taiwan, 2016. Emerg Infect Dis. 2017; 23(7):1180-1183. PMC: 5512481. DOI: 10.3201/eid2307.170212. View